🔎 Trials Near Me

Utama › Penyakit Paru Interstisial › Arizona

Kajian klinikal Penyakit Paru Interstisial di Arizona

13 kajian untuk Penyakit Paru Interstisial sedang mencari peserta di lokasi di Arizona.

Bandar di Arizona

Teks kajian rasmi (Bahasa Inggeris)

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • Arizona Heart Rhythm Center, Phoenix
  • University of Arizona, Tucson
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT05798923

Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease

  • Phoenix, Phoenix
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 8 Sep 2026 · NCT07473700

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

  • GSK Investigational Site, Scottsdale
  • GSK Investigational Site, Scottsdale
  • GSK Investigational Site, Tucson
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT05878717

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

  • Banner University Medical Center, Phoenix
  • Dignity Health - St. Joseph's Hospital and Medical Center-Norton Thoracic Institute, Phoenix
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT06911632

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

  • Dignity Health - St. Joseph's Hospital and Medical Center, Phoenix
  • Arizona Pulmonary Specialists, Ltd., Scottsdale
Mengambil pesertaFasa 3
Umur 18 hingga 80 · Semua jantina · Dikemas kini 2 Sep 2026 · NCT07285655

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • Banner Health - University Medical Center Phoenix, Phoenix
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT06388421

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

  • University of Arizona, Tucson
Mengambil pesertaKajian pemerhatian
Umur 21 ke atas · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT01915511

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

  • Arizona Pulmonary Specialists, Phoenix
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 10 Ogo 2026 · NCT07175038

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  • Banner University Medical Center Phoenix Lung Institute, Phoenix
  • Norton Thoracic Institute, Phoenix
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Jul 2026 · NCT05943535

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

  • Arizona Pulmonary Specialists, Phoenix
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 80 · Semua jantina · Dikemas kini 26 Jun 2026 · NCT06129240

Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease

  • Mayo Clinic in Arizona, Scottsdale
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Mac 2026 · NCT06751069

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

  • HonorHealth Research Institute, Scottsdale
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 12 Nov 2025 · NCT05975983

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.